Eli Lilly (LLY) Stock Doubles Down on Genetic Medicine With Engage Bio Buyout
TLDR Eli Lilly (LLY) has acquired preclinical biotech Engage Biologics for up to $202M in cash. Engage Bio has developed the Tethosome platform, a non-viral DNA delivery system using lipid nanoparticle and mRNA technology. The […]
